Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Tumors Characterized by Genetic Alterations in Anaplastic Lymphoma Kinase (ALK) × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 33 Carcinoma, Non-Small-Cell Lung 30 Prostatic Neoplasms 29 Lymphoma 21 Neoplasms 19 Multiple Myeloma 19 Melanoma 18 Leukemia, Myeloid, Acute 18 Squamous Cell Carcinoma of Head and Neck 15 Neoplasm Metastasis 15 Lung Neoplasms 14 Ovarian Neoplasms 12 Hematologic Neoplasms 12 Fallopian Tube Neoplasms 11 Triple Negative Breast Neoplasms 10 Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Myelodysplastic Syndromes 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Colorectal Neoplasms 10 Recurrence 9 Lymphoma, Non-Hodgkin 9 Brain Neoplasms 9 Lymphoma, Follicular 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Carcinoma, Renal Cell 8 Urinary Bladder Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Glioblastoma 7 Pancreatic Neoplasms 6 Neuroendocrine Tumors 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡